Income Tax Expense (Benefit) in USD of NEUROCRINE BIOSCIENCES INC from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Neurocrine Biosciences Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to Q3 2025.
  • Neurocrine Biosciences Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $82.3M, a 36% increase year-over-year.
  • Neurocrine Biosciences Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $201M, a 47.8% increase year-over-year.
  • Neurocrine Biosciences Inc annual Income Tax Expense (Benefit) for 2024 was $145M, a 75.6% increase from 2023.
  • Neurocrine Biosciences Inc annual Income Tax Expense (Benefit) for 2023 was $82.4M, a 38.7% increase from 2022.
  • Neurocrine Biosciences Inc annual Income Tax Expense (Benefit) for 2022 was $59.4M, a 403% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

NEUROCRINE BIOSCIENCES INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $201M $82.3M +$21.8M +36% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 $179M $52M +$18.4M +54.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 $160M $6.8M +$15.7M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q4 2024 $145M $59.5M +$9M +17.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-10
Q3 2024 $136M $60.5M +$28M +86.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 $108M $33.6M +$7.5M +28.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 $100M -$8.9M +$17.8M +66.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q4 2023 $82.4M $50.5M +$21.6M +74.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-10
Q3 2023 $60.8M $32.5M +$3.1M +10.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $57.7M $26.1M +$32.5M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $25.2M -$26.7M -$34.2M -456% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $59.4M $28.9M +$35.4M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-10
Q3 2022 $24M $29.4M +$21.4M +268% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $2.6M -$6.4M -$21.6M -142% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $24.2M $7.5M +$12.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $11.8M -$6.5M +$300M +97.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 -$288M $8M +$7.5M +1500% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$295M $15.2M +$11.6M +322% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$307M -$4.9M -$6.4M -427% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$301M -$306M -$311M -6757% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $10.2M $500K -$4.1M -89.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $14.3M $3.6M +$2.8M +350% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $11.5M $1.5M +$2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.5M $4.6M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $4.6M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $800K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$500K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06

NEUROCRINE BIOSCIENCES INC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $145M +$62.3M +75.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-10
2023 $82.4M +$23M +38.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-10
2022 $59.4M +$47.6M +403% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-10
2021 $11.8M +$312M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 -$301M -$310M -3264% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $9.5M +$8.8M +1257% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $700K +$700K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-02-08
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 $0 $0 Jan 1, 2012 Dec 31, 2012 10-K 2015-02-09
2011 $0 Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.